Citation Impact
Citing Papers
TH2-Polarized CD4+ T Cells and Macrophages Limit Efficacy of Radiotherapy
2015
Anti-CTLA-4 Immunotherapy Does Not Deplete FOXP3+ Regulatory T Cells (Tregs) in Human Cancers
2018 StandoutNobel
PD-1 + regulatory T cells amplified by PD-1 blockade promote hyperprogression of cancer
2019 StandoutNobel
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
mRNA-based vaccines synergize with radiation therapy to eradicate established tumors
2014
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
The ever-expanding role of HIF in tumour and stromal biology
2016
Dendritic cells in cancer immunology and immunotherapy
2019 Standout
Myeloid-derived suppressor cells coming of age
2018 Standout
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Epithelial–mesenchymal transition: a new target in anticancer drug discovery
2016
Combining Immune Checkpoint Inhibitors With Conventional Cancer Therapy
2018
Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy
2020
Dual prognostic significance of tumour-associated macrophages in human pancreatic adenocarcinoma treated or untreated with chemotherapy
2015
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
2016 Standout
The role of myeloid cells in cancer therapies
2016
The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy
2019 Standout
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
2019 Standout
Microenvironmental regulation of therapeutic response in cancer
2014
Tumor-associated macrophages and anti-tumor therapies: complex links
2016
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
2021 Standout
Understanding the tumor immune microenvironment (TIME) for effective therapy
2018 Standout
The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence
2015 Standout
Hypoxia-Inducible Factors: Master Regulators of Cancer Progression
2016 StandoutNobel
Natural and therapy-induced immunosurveillance in breast cancer
2015
Hepatocellular carcinoma
2021 Standout
Immunogenic cell death in cancer and infectious disease
2016 Standout
The immune contexture in cancer prognosis and treatment
2017 Standout
Tumor-Associated Macrophages: From Mechanisms to Therapy
2014 Standout
Spatiotemporal co-dependency between macrophages and exhausted CD8+ T cells in cancer
2022
Emerging Concepts for Immune Checkpoint Blockade-Based Combination Therapies
2018
The hypoxic tumor microenvironment: A driving force for breast cancer progression
2015 StandoutNobel
Macrophages in Tissue Repair, Regeneration, and Fibrosis
2016 Standout
Immune-mediated mechanisms influencing the efficacy of anticancer therapies
2015
Macrophages and cancer: from mechanisms to therapeutic implications
2015
TNF Counterbalances the Emergence of M2 Tumor Macrophages
2015
Acute myeloid leukemia cells polarize macrophages towards a leukemia supporting state in a Growth factor independence 1 dependent manner
2016
CDKN1A regulates Langerhans cell survival and promotes Treg cell generation upon exposure to ionizing irradiation
2015
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
2017
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth
2023 Standout
Chemokines in the cancer microenvironment and their relevance in cancer immunotherapy
2017 Standout
Macrophages as regulators of tumour immunity and immunotherapy
2019 Standout
Radiotherapy: Changing the Game in Immunotherapy
2016
Tumour-associated macrophages as treatment targets in oncology
2017 Standout
Combination cancer immunotherapies tailored to the tumour microenvironment
2015
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
2022 Standout
Exosomes facilitate therapeutic targeting of oncogenic KRAS in pancreatic cancer
2017 StandoutNature
Macrophage M1/M2 polarization
2020 Standout
Radiation for Awakening the Dormant Immune System, a Promising Challenge to be Explored
2014
Neutrophils in cancer: neutral no more
2016 Standout
In situ vaccination by radiotherapy to improve responses to anti-CTLA-4 treatment
2015
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy
2017 Standout
Radiation Therapy Induces Macrophages to Suppress T-Cell Responses Against Pancreatic Tumors in Mice
2016
Clinical relevance of tumour-associated macrophages
2022
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
The Nature of Myeloid-Derived Suppressor Cells in the Tumor Microenvironment
2016 Standout
Tumor microenvironment and cancer therapy resistance
2015
Macrophage Polarization
2016 Standout
Tumor-induced myeloid deviation: when myeloid-derived suppressor cells meet tumor-associated macrophages
2015
Ultraviolet B–Induced Maturation of CD11b-Type Langerin− Dendritic Cells Controls the Expansion of Foxp3+ Regulatory T Cells in the Skin
2017 StandoutNobel
Control of immune cell entry through the tumour vasculature: a missing link in optimising melanoma immunotherapy?
2017
EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
2017 Standout
PD-L1 (B7-H1) and PD-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations
2016 Standout
The interaction of anticancer therapies with tumor-associated macrophages
2015
Mature dendritic cells enriched in regulatory molecules may control regulatory T cells and the prognosis of head and neck cancer
2022 StandoutNobel
Chemotherapy induces enrichment of CD47 + /CD73 + /PDL1 + immune evasive triple-negative breast cancer cells
2018 StandoutNobel
Wound Healing: A Cellular Perspective
2018 Standout
Radiotherapy combination opportunities leveraging immunity for the next oncology practice
2016
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Immune Modulation of Head and Neck Squamous Cell Carcinoma and the Tumor Microenvironment by Conventional Therapeutics
2019
Combination therapy strategies for improving PD‐1 blockade efficacy: a new era in cancer immunotherapy
2017 StandoutNobel
Role of Local Radiation Therapy in Cancer Immunotherapy
2015
The Tumor Microenvironment Innately Modulates Cancer Progression
2019 Standout
HIF-1 regulates CD47 expression in breast cancer cells to promote evasion of phagocytosis and maintenance of cancer stem cells
2015 StandoutNobel
Genetics and biology of pancreatic ductal adenocarcinoma
2016
Rational Design of Bisphosphonate Lipid-like Materials for mRNA Delivery to the Bone Microenvironment
2022 StandoutNobel
Functional TRAIL receptors in monocytes and tumor-associated macrophages: A possible targeting pathway in the tumor microenvironment
2016
Less Can Be More: The Hormesis Theory of Stress Adaptation in the Global Biosphere and Its Implications
2021
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Combination of radiotherapy and vaccination overcomes checkpoint blockade resistance
2016
Macrophage plasticity, polarization, and function in health and disease
2018 Standout
Hyper-Progressive Disease: The Potential Role and Consequences of T-Regulatory Cells Foiling Anti-PD-1 Cancer Immunotherapy
2020 StandoutNobel
Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia
2015
Works of Noemi Bender being referenced
Low-Dose Irradiation Programs Macrophage Differentiation to an iNOS+/M1 Phenotype that Orchestrates Effective T Cell Immunotherapy
2013
Macrophage-derived nitric oxide initiates T-cell diapedesis and tumor rejection
2016